R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Manager, CMC Regulatory Affairs - Biologics - Combination Products

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-time$108k - $176k /yr

About the Job

Requirements

  • A bachelor's degree with 6 or more years, or an advanced degree with 3 or more years, in pharmaceutical, biotechnology, or Health Authority settings.
  • 2–4 years of CMC Regulatory Affairs experience with worldwide regulations.
  • A strong understanding of global CMC Regulatory Affairs requirements.
  • Experience delivering CMC sections of marketing authorizations, CTA/INDs, and post-approval submissions.
  • Strong communication, negotiation, strategic thinking, and problem-solving skills.
  • Ability to build cross-functional partnerships, manage competing priorities, and deliver results in dynamic environments.
  • Ability to support training activities and proactively address technical or regulatory knowledge gaps.

Responsibilities

  • Lead CMC regulatory strategies for assigned biologic products.
  • Support CMC development through early phase, submission, and post-market activities.
  • Assess changes and deviations for regulatory impact and filing requirements.
  • Review regulatory filings for compliance with applicable regulations and guidelines.
  • Support regulatory authority interactions, including meetings and information request responses.
  • Develop Working Instructions, SOPs, and Reviewer’s Guides to improve consistency.
  • Identify regulatory process gaps and recommend efficiency improvements.
  • Translate ambiguity into actionable steps and build alignment across teams.

Desired Qualifications

  • Experience with combination products.
  • Experience supporting biologic products.
  • Experience engaging with FDA or other regulatory authorities.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs